Abstract:Drug product performance testing is an important part of quality-by-design approaches, but this process often lacks the underlying mechanistic understanding of the complex interactions between the disintegration and dissolution processes involved. Whereas a recent draft guideline by the US Food and Drug Administration (FDA) has allowed the replacement of dissolution testing with disintegration testing, the mentioned criteria are not globally accepted. This study provides scientific justification for using disintegration testing rather than dissolution testing as a quality control method for certain immediate release (IR) formulations. A mechanistic approach, which is beyond the current FDA criteria, is presented. Dissolution testing via United States Pharmacopeial Convention Apparatus II at various paddle speeds was performed for immediate and extended release formulations of metronidazole. Dissolution profile fitting via DDSolver and dissolution profile predictions via DDDPlus™ were performed. The results showed that Fickian diffusion and drug particle properties (DPP) were responsible for the dissolution of the IR tablets, and that formulation factors (eg, coning) impacted dissolution only at lower rotation speeds. Dissolution was completely formulation controlled if extended release tablets were tested and DPP were not important. To demonstrate that disintegration is the most important dosage form attribute when dissolution is DPP controlled, disintegration, intrinsic dissolution and dissolution testing were performed in conventional and disintegration impacting media (DIM). Tablet disintegration was affected by DIM and model fitting to the Korsmeyer-Peppas equation showed a growing effect of the formulation in DIM. DDDPlus was able to predict tablet dissolution and the intrinsic dissolution profiles in conventional media and DIM. The study showed that disintegration has to occur before DPP-dependent dissolution can happen. The study suggests that disintegration can be used as performance test of rapidly disintegrating tablets beyond the FDA criteria. The scientific criteria and justification is that dissolution has to be DPP dependent, originated from active pharmaceutical ingredient characteristics and formulations factors have to be negligible.

Intrinsic dissolution rate modeling for the pharmacopoeia apparatus rotating disk compared to flow channel method

Theoretical Analysis of Drug Dissolution: I. Solubility and Intrinsic Dissolution Rate

Flexible modelling of the dissolution performance of directly compressed tablets

In vitro and in silico methods to investigate the effect of moderately increasing medium viscosity and density on ibuprofen dissolution rate

Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

The Key Role of Wettability and Boundary Layer in Dissolution Rate Test

Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution

Prediction of Dissolution Profiles from Process Parameters, Formulation and Spectroscopic Measurements.

A two-stage mechanistic reduced-order model of pharmaceutical tablet dissolution: Population balance modeling and tablet wetting functions

Dissolution of irregularly-shaped drug particles: mathematical modelling

Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media

Probing Differences in Mass-Transfer Coefficients in Beaker and Stirrer Digestion Systems and the USP Dissolution Apparatus 2 Using Benzoic Acid Tablets

Film Formation in a Horizontal Twin-Shaft Rotating Disk Reactor for Polymer Devolatilization

Comprehensive kinetic model for the dissolution, reaction, and crystallization processes involved in the synthesis of aspirin

Modelling drug degradation of amorphous solid dispersion during twin-screw extrusion

Development of in Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms

Measuring and Modeling of Melt Viscosity for Drug Polymer Mixtures

First-Principles and Empirical Approaches to Predicting in Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing

Computational study of free surface film flow and subsequent disintegration of a sheet and ligaments into droplets from a rotary disk atomizer

Biphasic Dissolution as an Exploratory Method during Early Drug Product Development